NCT02763111View on ClinicalTrials.gov

Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Ankylosing Spondylitis
Interventions
DRUG

BCD-085

OTHER

Placebo

Sponsors

Lead Sponsor

Biocad
All Listed Sponsors
lead

Biocad

INDUSTRY